• Consensus Rating: Buy
  • Consensus Price Target: GBX 2,370
  • Forecasted Upside: 169.65%
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
GBX 878.92
▲ +18.924 (2.20%)

This chart shows the closing price for CVSG by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New CVS Group Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CVSG and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CVSG

Analyst Price Target is GBX 2,370
▲ +169.65% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for CVS Group in the last 3 months. The average price target is GBX 2,370, with a high forecast of GBX 2,370 and a low forecast of GBX 2,370. The average price target represents a 169.65% upside from the last price of GBX 878.92.

This chart shows the closing price for CVSG for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 1 polled investment analysts is to buy stock in CVS Group. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/12/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/10/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/9/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/8/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/6/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/4/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/3/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/3/2024

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
7/25/2024Berenberg BankReiterated RatingBuyGBX 2,370
5/21/2024Berenberg BankReiterated RatingBuyGBX 2,370
2/29/2024Berenberg BankReiterated RatingBuyGBX 2,370
1/25/2024Berenberg BankReiterated RatingBuyGBX 2,370
12/4/2023Royal Bank of CanadaReiterated RatingOutperformGBX 1,900
9/19/2023Berenberg BankReiterated RatingBuyGBX 2,370
2/24/2023Berenberg BankReiterated RatingBuyGBX 2,370
2/24/2023Numis SecuritiesReiterated RatingBuyGBX 2,300
11/8/2022Berenberg BankReiterated RatingBuyGBX 2,370
11/2/2022Royal Bank of CanadaBoost TargetOutperformGBX 2,200 ➝ GBX 2,300
9/22/2022Berenberg BankReiterated RatingBuyGBX 2,370
7/28/2022Berenberg BankLower TargetBuyGBX 2,900 ➝ GBX 2,370
5/27/2022Royal Bank of CanadaLower TargetOutperformGBX 3,000 ➝ GBX 2,200
3/24/2022Royal Bank of CanadaReiterated RatingOutperformGBX 3,000
3/24/2022Berenberg BankReiterated RatingBuyGBX 2,900
2/4/2022Royal Bank of CanadaReiterated RatingOutperformGBX 3,000
1/27/2022Berenberg BankReiterated RatingBuyGBX 2,900
11/30/2021Berenberg BankReiterated RatingBuyGBX 2,900
10/7/2021Royal Bank of CanadaBoost TargetOutperformGBX 2,750 ➝ GBX 3,100
7/20/2021Berenberg BankBoost TargetBuyGBX 2,400 ➝ GBX 2,630
6/7/2021Royal Bank of CanadaReiterated RatingOutperformGBX 2,750
5/18/2021Numis SecuritiesReiterated RatingHoldGBX 2,200
4/29/2021Berenberg BankBoost TargetBuyGBX 2,200 ➝ GBX 2,400
8/24/2020Liberum CapitalInitiated CoverageHoldGBX 1,274
7/24/2020Berenberg BankReiterated RatingBuyGBX 1,400
7/24/2020Peel HuntBoost TargetBuyGBX 1,130 ➝ GBX 1,230
7/2/2020Peel HuntReiterated RatingBuy
6/12/2020Royal Bank of CanadaBoost TargetSector PerformerGBX 600 ➝ GBX 1,070
6/3/2020Peel HuntReiterated RatingBuy
5/1/2020Peel HuntReiterated RatingBuy
4/15/2020Berenberg BankReiterated RatingBuy
4/7/2020Peel HuntReiterated RatingBuy
3/27/2020Peel HuntLower TargetBuyGBX 1,150 ➝ GBX 1,130
3/16/2020Berenberg BankReiterated RatingBuy
3/5/2020Peel HuntReiterated RatingBuy
2/7/2020Berenberg BankBoost TargetBuyGBX 1,200 ➝ GBX 1,400
2/3/2020Peel HuntReiterated RatingBuyGBX 1,150 ➝ GBX 1,250
1/20/2020Peel HuntReiterated RatingBuy
1/10/2020Peel HuntReiterated RatingBuy
12/5/2019Peel HuntReiterated RatingBuy
(Data available from 12/4/2019 forward)

News Sentiment Rating

0.13 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 5 positive mentions
  • 5 negative mentions
  • 1 very negative mentions
5/8/2024
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
6/7/2024
  • 2 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/7/2024
  • 3 very positive mentions
  • 3 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
8/6/2024
  • 1 very positive mentions
  • 4 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
9/5/2024
  • 2 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/5/2024
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
11/4/2024
  • 1 very positive mentions
  • 8 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
12/4/2024

Current Sentiment

  • 1 very positive mentions
  • 8 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
CVS Group logo
CVS Group plc, together with its subsidiaries, engages in veterinary, pet crematoria, online pharmacy, and retail businesses. The company operates through four segments: Veterinary Practices, Laboratories, Crematoria, and Online Retail Business. It operates in animal veterinary practices and complementary veterinary diagnostic businesses. The company also provides pet cremation and clinical waste disposal services for veterinary practices. In addition, it operates Animed Direct, an online retail business that sells prescription and non-prescription medicines, pet foods, and other pet care products; and an online dispensary. Further, the company provides burial grounds; veterinary instrumentation supply; and property development services. It owns veterinary practices, laboratories, and crematories in the United Kingdom, Australia, the Netherlands, and the Republic of Ireland. CVS Group plc was founded in 1999 and is headquartered in Diss, the United Kingdom.
Read More

Today's Range

Now: GBX 878.92
Low: 858
High: 881

50 Day Range

MA: GBX 939.70
Low: 798
High: 1,176

52 Week Range

Now: GBX 878.92
Low: 791
High: 1,749

Volume

119,281 shs

Average Volume

311,899 shs

Market Capitalization

£630.54 million

P/E Ratio

2,441.46

Dividend Yield

0.72%

Beta

1.02

Frequently Asked Questions

What sell-side analysts currently cover shares of CVS Group?

The following Wall Street research analysts have issued reports on CVS Group in the last twelve months: Berenberg Bank, and Royal Bank of Canada.
View the latest analyst ratings for CVSG.

What is the current price target for CVS Group?

0 Wall Street analysts have set twelve-month price targets for CVS Group in the last year. Their average twelve-month price target is GBX 2,370, suggesting a possible upside of 169.6%. Berenberg Bank has the highest price target set, predicting CVSG will reach GBX 2,370 in the next twelve months. Berenberg Bank has the lowest price target set, forecasting a price of GBX 2,370 for CVS Group in the next year.
View the latest price targets for CVSG.

What is the current consensus analyst rating for CVS Group?

CVS Group currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe CVSG will outperform the market and that investors should add to their positions of CVS Group.
View the latest ratings for CVSG.

What other companies compete with CVS Group?

How do I contact CVS Group's investor relations team?

CVS Group's physical mailing address is C V S House, Owen Road, DISS, IP22 4ER, United Kingdom. The company's listed phone number is +44-1379-644288. The official website for CVS Group is www.cvsukltd.co.uk. Learn More about contacing CVS Group investor relations.